retatrutide ly3437943 glp-1 gip glucagon receptor agonist vs Tirzepatide: Comprehensive Comparison - Which Is Better? | PPW Retatrutide—the novel triple GIP/GLP-1/glucagon receptor

This evidence suggests that despite their success in achieving initial weight loss, these drugs alone may not be sufficient for long term weight control, say the researchers

The human body is shrewd and will strive for balance through a number of different metabolic adaptations

These foundations are at the core of everything we do

Administration burden ranges from twice daily to once weekly

Stir in diced apple and flaxseed, then sprinkle with walnuts and cinnamon before serving

In phase 2 trials, retatrutide produced mean weight loss of 24.2% at 48 weeks at the highest dose, which exceeds the results of any currently approved single agent at the same timepoint